These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29456841)

  • 21. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
    J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variables determining mortality in patients with Acinetobacter baumannii meningitis/ventriculitis treated with intrathecal colistin.
    Ceylan B; Arslan F; Sipahi OR; Sunbul M; Ormen B; Hakyemez İN; Turunc T; Yıldız Y; Karsen H; Karagoz G; Tekin R; Hizarci B; Turhan V; Senol S; Oztoprak N; Yılmaz M; Ozdemir K; Mermer S; Kokoglu OF; Mert A
    Clin Neurol Neurosurg; 2017 Feb; 153():43-49. PubMed ID: 28013184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged and high dosage of tigecycline - successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report.
    Tsachouridou O; Georgiou A; Nanoudis S; Chrysanthidis T; Loli G; Morfesis P; Zebekakis P; Metallidis S
    J Med Case Rep; 2017 Jul; 11(1):186. PubMed ID: 28687078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
    Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
    Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology.
    Sands M; McCarter Y; Sanchez W
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):521-2. PubMed ID: 17558487
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.
    Kassamali Z; Jain R; Danziger LH
    Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study.
    Wang JH; Lin PC; Chou CH; Ho CM; Lin KH; Tsai CT; Wang JH; Chi CY; Ho MW
    J Microbiol Immunol Infect; 2014 Jun; 47(3):204-10. PubMed ID: 23201321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods.
    Tan TY; Lim TP; Lee WH; Sasikala S; Hsu LY; Kwa AL
    Antimicrob Agents Chemother; 2011 Jan; 55(1):436-8. PubMed ID: 20956606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPR741, an Antibiotic Adjuvant, Potentiates the
    Zurawski DV; Reinhart AA; Alamneh YA; Pucci MJ; Si Y; Abu-Taleb R; Shearer JP; Demons ST; Tyner SD; Lister T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947471
    [No Abstract]   [Full Text] [Related]  

  • 35. Colistin and tigecycline for management of external ventricular device-related ventriculitis due to multidrug-resistant Acinetobacter baumannii.
    Shrestha GS; Tamang S; Paneru HR; Shrestha PS; Keyal N; Acharya SP; Marhatta MN; Shilpakar S
    J Neurosci Rural Pract; 2016; 7(3):450-2. PubMed ID: 27365967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections.
    Rigatto MH; Vieira FJ; Antochevis LC; Behle TF; Lopes NT; Zavascki AP
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6575-80. PubMed ID: 26259799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.
    Chung JH; Bhat A; Kim CJ; Yong D; Ryu CM
    Sci Rep; 2016 Jun; 6():28168. PubMed ID: 27306928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post Trauma Acinetobacter Baumanii Meningitis Treatment Approach.
    Erdoğan C; Balcioglu ZB; Seida I; Kizilaslan D
    Ulus Travma Acil Cerrahi Derg; 2024 Mar; 30(3):221-225. PubMed ID: 38506388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.